Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07805993

Feasibility of Egg White Pudding Supplementation for Individuals in Personal Care Home Centres Needing Dietary Supplementation

This trial is an open-label randomized controlled parallel arm feasibility trial. 54 residents in care homes receiving nutrition supplementation (minimum 40% of each sex, ≥ 50 years of age). Participants will receive the egg white pudding (experimental) or a standard currently provided dietary supplement (control) on a daily basis and will be advised to follow any dietary recommendations they receive from their care team. Participants will be recruited at personal care homes throughout Winnipeg. Study visits will take place with a study coordinator at baseline and at 8 weeks (endpoint). Product acceptability will be assessed through dietary logs. This study has been reviewed and approved by The Committee for Harmonized Health Impact, Privacy, and Ethics Review (CHIPER).

Recruiting

Interested in participating?

Request Info

Key information

Age range

50 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The Saul and Claribel Simkin Centre

Winnipeg, Manitoba, Canada

Location status: Recruiting

Location contact

Alanna Kull, RN

CONTACT

[email protected]

(204) 586-9781

About this study

This trial is an open-label randomized controlled parallel arm feasibility trial. 54 residents from non-shared health personal care home centres (target of a minimum 40% of each sex, ≥ 50 years of age) will be recruited. Participants will receive the egg white pudding (experimental) 5 days a week or a standard currently provided dietary supplement (control) 7 days a week and will be advised to follow any dietary recommendations they receive from their care team. The personal care home team will approach residents or their ADM to participate in the research. Once a potential participant confirms interest, the research team will approach them for scheduling a screening visit. As part of the screening process, the care team may provide the research team with information on the participant's MDS (Minimum Data Set) level, which is routinely collected by personal care homes in Canada (levels 1-3). This information will be recorded at the screening visit for descriptive purposes only and will not be used to exclude any participants. The research coordinator and research assistant will also oversee and document the dispensing of products, which will be administered by the care team at the home care centre. After the screening visit, study visits will take place with a research coordinator or research assistant at Week 1 (baseline) and at Week 8 (endpoint). Product acceptability will be assessed through feedback questionnaire.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Residing in a partnering Personal Care Home
  • Participant is willing and able to give informed consent for participation in the trial or has an ADM who is authorized to provide consent on their behalf.
  • Male or female aged ≥50 years

Exclusion criteria

  • Allergy to eggs
  • Inability to consume treatment product
  • Unable to provide written consent
  • Unable to understand English
  • Does not have an ADM

Treatment and study plan

Egg White Pudding

Dietary Supplement

Participants will be given a high protein egg white pudding 5 days a week for 8 weeks.

Nestle Resource

Dietary Supplement

Participants in the control group will be given 180 ml of Resource 2.0 seven days a week for 8 weeks.

Primary outcomes

  1. Hand Grip Strength

    Time frame: 8 weeks

    Hand grip strength will be measured using a specialized handheld device called a hand dynamometer that records the maximum isometric force generated in kilograms or pounds.

Secondary outcomes

  1. Waist circumference

    Time frame: 8 weeks

    The study staff will wrap a flexible tape measure around participants' middle at the level of the belly button or just above the hip bones.

  2. Body weight

    Time frame: 8 weeks

    Body weight will be measured by participants stepping onto a digital or mechanical weighing scale placed on a hard, flat surface

  3. Calf Circumference

    Time frame: 8 weeks

    The study staff will wrap a flexible tape measure around the widest part of participants' lower leg while keeping the tape snug but comfortable.

Study contacts

Contact information is provided by the study sponsor or research team.

Maryem Zahra, BA

CONTACT

[email protected]

204-631-3834

Navdeep Tangri, MD, PhD

CONTACT

[email protected]

204-631-3834

Sponsors and collaborators

Lead sponsor

Seven Oaks Hospital Chronic Disease Innovation Centre

Network

Registry information

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Sep 8, 2026
Registry last updated
Sep 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.